This inhibition was specifically replicated in non-small-cell lung cancer NSCLC and SCLC cell lines and supported by obtaining the same results after the inhibition of MET via knock-down with a small interference RNA (siRNA) [33,78]. The gene discussed is MET; the disease is small cell lung carcinoma.